ArticleClinical drug investigation2018

A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma.

Dan-Dan Xiong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.